These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 3092344)

  • 21. The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome.
    McLean AJ; Harrison PM; Ioannides-Demos L; Byrne AJ; McCarthy P; Dudley FJ
    Aust N Z J Med; 1985 Jun; 15(3):367-74. PubMed ID: 3904700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of aggressive factors in the pathogenesis of peptic ulcer disease.
    Richardson CT
    Scand J Gastroenterol Suppl; 1990; 174():37-43. PubMed ID: 2119515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between inhibition of acid secretion and healing of peptic ulcers.
    Chiverton SG; Hunt RH
    Scand J Gastroenterol Suppl; 1989; 166():43-7; discussion 74-5. PubMed ID: 2690331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aetiology of peptic ulcer.
    Lam SK
    Ann Acad Med Singap; 1983 Oct; 12(4):498-506. PubMed ID: 6378055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it really more difficult to treat prepyloric ulcers?
    Halter F; Eigenmann F
    Aliment Pharmacol Ther; 1987; 1 Suppl 1():433S-438S. PubMed ID: 2979694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prepyloric erosions and related changes.
    Berstad A; Nesland A
    Scand J Gastroenterol; 1985 Sep; 20(7):779-82. PubMed ID: 3901234
    [No Abstract]   [Full Text] [Related]  

  • 27. Results of short- and long-term cimetidine treatment in patients with juxtapyloric ulcers, with special reference to gastric acid and pepsin secretion.
    Ström M; Berstad A; Bodemar G; Walan A
    Scand J Gastroenterol; 1986 Jun; 21(5):521-30. PubMed ID: 3092344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics of roxatidine acetate: a review.
    Dammann HG; de Looze SM; Bender W; Labs R
    Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer.
    de Bruijne JW; Snel P; Lamers CB
    Digestion; 1989; 44 Suppl 1():25-30. PubMed ID: 2691308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine. I. Developments, pharmacology, and efficacy.
    Freston JW
    Ann Intern Med; 1982 Oct; 97(4):573-80. PubMed ID: 6751184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical therapy of peptic ulcer disease.
    McQuaid KR; Isenberg JI
    Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.